MMPX1988

MMPX1988 is an investigational topical drug candidate being developed by Memidis Pharma for the treatment of Lichen Sclerosus (LS). Formulated as a topical ointment, it is described as having potent anti-inflammatory effects and properties that facilitate skin restoration and regeneration. Lichen Sclerosus is a chronic inflammatory skin condition that primarily affects the genital and anal areas, leading to symptoms such as itching, pain, and scarring. MMPX1988 aims to address the underlying inflammation and tissue damage associated with the disease. As of 2024, the candidate is in the discovery phase of development.